These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 1966804

  • 21. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M, Delaunois A, Gustin P, Godeau JM, Lekeux P.
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [Abstract] [Full Text] [Related]

  • 22. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor.
    Sugiura T, Tokumura A, Gregory L, Nouchi T, Weintraub ST, Hanahan DJ.
    Arch Biochem Biophys; 1994 Jun; 311(2):358-68. PubMed ID: 8203898
    [Abstract] [Full Text] [Related]

  • 23. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
    Salari H, Dryden P, Howard S, Bittman R.
    Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
    [Abstract] [Full Text] [Related]

  • 24. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
    Kertscher HP, Ostermann G.
    Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
    [Abstract] [Full Text] [Related]

  • 25. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z, Imura Y, Takatani M, Tsushima S, Nishikawa K.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [Abstract] [Full Text] [Related]

  • 26. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD, Morrison WJ, Dhar A.
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [Abstract] [Full Text] [Related]

  • 27. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM, Kulikov VI, Manevich EM, Muliar AG, Shvets VI.
    Farmakol Toksikol; 1988 Apr; 51(4):113-23. PubMed ID: 2847936
    [No Abstract] [Full Text] [Related]

  • 28. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE.
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [Abstract] [Full Text] [Related]

  • 29. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V, Mascarucci P, De Simoni MG, Jiang X, Bindoni M.
    Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
    [Abstract] [Full Text] [Related]

  • 30. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine.
    Tordai A, Franklin RA, Johnson C, Mazer BD, Clay KL, Gelfand EW.
    J Immunol; 1994 Jan 15; 152(2):566-73. PubMed ID: 8283038
    [Abstract] [Full Text] [Related]

  • 31. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 2000 Apr 15; 65(4):427-30. PubMed ID: 10810178
    [Abstract] [Full Text] [Related]

  • 32. [Antagonistic effect of myricetin on platelet activing factor].
    Zang BX, Jin M, Wu W, Chen WM, Piao YZ, Li JR.
    Yao Xue Xue Bao; 2003 Nov 15; 38(11):831-3. PubMed ID: 14991995
    [Abstract] [Full Text] [Related]

  • 33. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun 15; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

  • 34. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
    Hayashi H, Kudo I, Inoue K, Onozaki K, Tsushima S, Nomura H, Nojima S.
    J Biochem; 1985 Jun 15; 97(6):1737-45. PubMed ID: 2993272
    [Abstract] [Full Text] [Related]

  • 35. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar 15; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 36. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
    James-Kracke MR, Sexe RB, Shukla SD.
    J Pharmacol Exp Ther; 1994 Nov 15; 271(2):824-31. PubMed ID: 7965802
    [Abstract] [Full Text] [Related]

  • 37. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
    Sugatani J, Fukazawa N, Ujihara K, Yoshinari K, Abe I, Noguchi H, Miwa M.
    Int Arch Allergy Immunol; 2004 May 15; 134(1):17-28. PubMed ID: 15051936
    [Abstract] [Full Text] [Related]

  • 38. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M, Sugatani J, Ino M, Shimura M, Akiyama M, Yamazaki R, Suzuki Y, Miwa M.
    Am J Physiol; 1998 Jan 15; 274(1):C47-57. PubMed ID: 9458712
    [Abstract] [Full Text] [Related]

  • 39. The mechanism of internalization of platelet-activating factor in activated human neutrophils. Enhanced transbilayer movement across the plasma membrane.
    Bratton DL, Dreyer E, Kailey JM, Fadok VA, Clay KL, Henson PM.
    J Immunol; 1992 Jan 15; 148(2):514-23. PubMed ID: 1309560
    [Abstract] [Full Text] [Related]

  • 40. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 15; 342(6):713-8. PubMed ID: 2096302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.